Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jesper Malmberg

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Carbohydrate Research|May 3, 2006
Aromatic O-glycosylationMårten Jacobsson, Jesper Malmberg, Ulf Ellervik
Bioorganic & Medicinal Chemistry|June 20, 2006
Synthesis of aromatic C-xylosides by position inversion of glucoseJesper Malmberg, Katrin Mani, Elin Säwén, et al.
Organic Letters|November 6, 2023
Selective C-H Iodination of Weinreb Amides and Benzamides through Iridium Catalysis in Solution and under Mechanochemical ConditionsAmparo Sanz-Marco, Beatriz Saavedra, Elis Erbing, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2016
Isoindolinone compounds active as Kv1.5 blockers identified using a multicomponent reaction approachJohan Kajanus, Ingemar Jacobson, Annika Åstrand, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2Stefan von Berg, Yafeng Xue, Mia Collins, et al.
Journal of Medicinal Chemistry|August 11, 2018
Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based DesignFrank Narjes, Yafeng Xue, Stefan von Berg, et al.
Journal of Medicinal Chemistry|February 10, 2018
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect ProfileLena Ripa, Karl Edman, Matthew Dearman, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2014
Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channelRoine I Olsson, Ingemar Jacobson, Tommy Iliefski, et al.
RSC Medicinal Chemistry|July 14, 2025
Topical BET PROTACs for locally restricted protein degradation in the lungMartin Hemmerling, Jianming Liu, Antonio Piras, et al.
Journal of Medicinal Chemistry|August 31, 2021
AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2Frank Narjes, Antonio Llinas, Stefan von Berg, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Carbohydrate Research|May 3, 2006
Aromatic O-glycosylationMårten Jacobsson, Jesper Malmberg, Ulf Ellervik
Bioorganic & Medicinal Chemistry|June 20, 2006
Synthesis of aromatic C-xylosides by position inversion of glucoseJesper Malmberg, Katrin Mani, Elin Säwén, et al.
Organic Letters|November 6, 2023
Selective C-H Iodination of Weinreb Amides and Benzamides through Iridium Catalysis in Solution and under Mechanochemical ConditionsAmparo Sanz-Marco, Beatriz Saavedra, Elis Erbing, et al.
Bioorganic & Medicinal Chemistry Letters|March 12, 2016
Isoindolinone compounds active as Kv1.5 blockers identified using a multicomponent reaction approachJohan Kajanus, Ingemar Jacobson, Annika Åstrand, et al.
ACS Medicinal Chemistry Letters|June 22, 2019
Discovery of Potent and Orally Bioavailable Inverse Agonists of the Retinoic Acid Receptor-Related Orphan Receptor C2Stefan von Berg, Yafeng Xue, Mia Collins, et al.
Journal of Medicinal Chemistry|August 11, 2018
Potent and Orally Bioavailable Inverse Agonists of RORγt Resulting from Structure-Based DesignFrank Narjes, Yafeng Xue, Stefan von Berg, et al.
Journal of Medicinal Chemistry|February 10, 2018
Discovery of a Novel Oral Glucocorticoid Receptor Modulator (AZD9567) with Improved Side Effect ProfileLena Ripa, Karl Edman, Matthew Dearman, et al.
Bioorganic & Medicinal Chemistry Letters|February 12, 2014
Lactam sulfonamides as potent inhibitors of the Kv1.5 potassium ion channelRoine I Olsson, Ingemar Jacobson, Tommy Iliefski, et al.
RSC Medicinal Chemistry|July 14, 2025
Topical BET PROTACs for locally restricted protein degradation in the lungMartin Hemmerling, Jianming Liu, Antonio Piras, et al.
Journal of Medicinal Chemistry|August 31, 2021
AZD0284, a Potent, Selective, and Orally Bioavailable Inverse Agonist of Retinoic Acid Receptor-Related Orphan Receptor C2Frank Narjes, Antonio Llinas, Stefan von Berg, et al.
Pageof 1